Alaunos Therapeutics | ZIOP - Interest Expense On Debt



Alaunos Therapeutics reported $0 in Interest Expense on Debt for its fiscal quarter ending in December of 2023.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Amgen USD 694M 29M Jun/2025
AstraZeneca 303M 126M Jun/2025
Baxter International USD 81M 19M Mar/2025
Biogen USD 72.6M 12.6M Jun/2025
Bioline Rx 276K 1.35M Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Corcept Therapeutics 6M 6M Jun/2024
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
Incyte USD 594K 66K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
J&J USD 128M 9M Mar/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Merck USD 305M 8M Jun/2025
Neuren Pharmaceuticals 0 0 Jun/2024
Novartis USD 289M 19M Jun/2025
Pfizer USD 654M 0 Jun/2025
PTC Therapeutics USD 30.36M 4.03M Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
TG Therapeutics USD 6.72M 4.12M Jun/2025
Tilray USD 7.77M 2.08M Nov/2024
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025